Products

wipshot

A new way to communicate creative work

wipshot.com Design / UI/UX Design & Prototyping

AI Benchmark
Monthly visits
<5K
Oct 2026
MRR
$1Claimed
Disclosed 2026-09-29Indie Hackers
Entry price
Unknown
No monthly subscription pricing
Creators
YoonHo Kim
@yoonho_kim_· 2 followers
Launched
6y ago
2020-10-01 · Est.

Traffic & revenue

Monthly visitsData through Oct 2026
MRRSelf-reported, unverified · Indie Hackers
  • Sep 2026$1Self-reported MRR · unverified
Events1 revenue disclosure

Revenue evidence

Publicly disclosed & verified revenue figures, sorted by date

Marketing moves

Launches, search & content, referrals, promotions
X accounts@yoonho_kim_
  • Launched on Product HuntLaunch

    A new way to communicate creative work

    Apr 25, 2021 · 5y agoLaunch page

  • Launched on BetaListLaunch

    Wipshot – Share with WIP and Review — Share with WIP and Review

    Oct 1, 2020 · 6y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority 0.7Domain registered 2020-01-02

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Website snapshots

Indexed 2021-04-25

Key pages

Desktop & mobile archive

Website snapshots pending capture.

Questions & evidence

How much website traffic does wipshot get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is wipshot and what platforms does it support?
wipshot is catalogued under UI/UX Design & Prototyping: A new way to communicate creative work. Supported platforms: Web.
What is wipshot's publicly disclosed revenue?
Indie Hackers records a founder-reported figure of $1 /mo stated on 2026-09-29.Source

Related products in this category

Design / UI/UX Design & Prototyping

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.